SCHOTT Pharma AG & Co. KGaA

OVERVALUED1SXP.F · FSX · Healthcare
1SXP.F·FSX·Healthcare
OVERVALUED
SCHOTT Pharma AG & Co. KGaA
24.3%downside
MARKET PRICE
$17.48
FAIR PRICE
$13.23
MARGIN
$4.25
UNDERVALUEDFAIROVERVALUED
P/E RATIO
17.6x
DIV. YIELD
1.05%
ROE
17.1%
MARKET CAP
$3B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

24.3%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$17.48

FAIR PRICE

$13.23

MARGIN

$4.25

UNDERVALUEDFAIROVERVALUED

P/E Ratio

17.6x

What is P/E? →

Div. Yield

1.05%

ROE

17.1%

Strong

Market Cap

$3B

Mid-cap

NOW AVAILABLE

Get notified when 1SXP.F's fair price changes

Push notifications when 1SXP.F's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

6.5/ 10

Stable earnings and revenue and low debt levels, but weak profitability margins and expensive valuation relative to fundamentals.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$10.58CONSERVATIVE ENTRY
$13.23FAIR PRICE
$17.48MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$10.58

Fair price × 0.80

DISTANCE

39.5%

Price to entry level

At the current price of $17.48, 1SXP.F trades 39.5% above the conservative entry level of $10.58. This entry level represents a 20% margin of safety below the calculated fair price of $13.23 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate 1SXP.F's fair price

SCHOTT Pharma AG & Co. KGaA's fair price of $13.23 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $17.48, 1SXP.F trades 24.3% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting 1SXP.F's risk profile.

RELATIVE · 30%

Comparing 1SXP.F's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for 1SXP.F, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate 1SXP.F's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for 1SXP.F.

Explore on Bulios

FAQ

What is the fair price of 1SXP.F?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for SCHOTT Pharma AG & Co. KGaA is $13.23. At the current market price of $17.48, 1SXP.F trades 24.3% above its calculated fair value.

Is 1SXP.F overvalued or undervalued?+

SCHOTT Pharma AG & Co. KGaA is currently overvalued based on our valuation model. The stock trades at $17.48, which is 24.3% above the fair price of $13.23. The P/E ratio of 17.6x is a key metric in the valuation.

What is the margin of safety for 1SXP.F?+

With a 20% margin of safety applied to the fair price of $13.23, the conservative entry level for 1SXP.F is $10.58. At the current market price of $17.48, the stock trades 39.5% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is 1SXP.F's fair price updated?+

We update fair price calculations for 1SXP.F daily after market close. The current fair price of $13.23 incorporates the latest market data and sector multiples.

What factors affect 1SXP.F's fair price calculation?+

1SXP.F's fair price of $13.23 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 17.6x, ROE of 17.1%, and dividend yield of 1.05%.

Is 1SXP.F a good buy right now?+

At $17.48, 1SXP.F trades 24.3% above our fair value estimate of $13.23. The stock is currently overvalued. ROE stands at 17.1% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does 1SXP.F pay dividends?+

1SXP.F has a dividend yield of 1.05%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.